ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality worldwide. The World Health Organization (WHO) estimates that reducing daily salt intake by 5 g could lower global CVD rates by up to 17%. In the Middle East, excessive salt consumption poses a critical public health challenge, contributing significantly to CVD and related conditions. This review examines salt reduction efforts across the region, focusing on policy interventions, implementation strategies, and barriers. Common initiatives include reformulation of staple foods, consumer education campaigns, and front‐of‐pack labeling (FOPL). However, progress is constrained by limited intake data, funding gaps, reliance on imports with unregulated salt content, and insufficient cross‐sector collaboration. Additional obstacles include socioeconomic disparities, political instability, workforce shortages, and industry resistance. To address these challenges, countries have adopted strategies involving stakeholder engagement, monitoring and evaluation systems, and consumer awareness programs. Evidence from selected case studies demonstrates the importance of integrating cost‐effectiveness considerations into policy design, particularly in resource‐constrained health systems. Overall, sustainable salt reduction in the Middle East requires stronger multi‐sectoral collaboration, robust surveillance mechanisms, and region‐specific adaptations to overcome unique social, economic, and political barriers.
Yakti et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: